{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T23:03:26Z","timestamp":1775516606350,"version":"3.50.1"},"reference-count":145,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.det.2026.01.011","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:35:36Z","timestamp":1771274136000},"page":"321-340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnosis of Autoimmune Blistering Diseases"],"prefix":"10.1016","volume":"44","author":[{"given":"Julia S.","family":"Lehman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.det.2026.01.011_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2020.11.076","article-title":"Subepithelial autoimmune blistering dermatoses: clinical features and diagnosis","volume":"85","author":"Montagnon","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2026.01.011_bib2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3181\/00379727-117-29622","article-title":"Demonstration of skin antibodies in sera of Pemphigus vulgaris patients by indirect immunofluorescent staining","volume":"117","author":"Beutner","year":"1964","journal-title":"Proc Soc Exp Biol Med"},{"issue":"5","key":"10.1016\/j.det.2026.01.011_bib3","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archderm.1971.04000170020004","article-title":"Direct immunofluorescent studies of pemphigus and bullous pemphigoid","volume":"103","author":"Jordon","year":"1971","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.det.2026.01.011_bib4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-2133.1999.02752.x","article-title":"Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus","volume":"140","author":"Amagai","year":"1999","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2026.01.011_bib5","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/1523-1747.ep12382738","article-title":"Development of an ELISA to detect anti-BP180 autoantibodies in bullous pemphigoid and herpes gestationis","volume":"102","author":"Giudice","year":"1994","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.det.2026.01.011_bib6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-0625.1995.tb00232.x","article-title":"Detection of autoantibodies against bullous pemphigoid and pemphigus antigens by an enzyme-linked immunosorbent assay using the bacterial recombinant proteins","volume":"4","author":"Ide","year":"1995","journal-title":"Exp Dermatol"},{"issue":"1","key":"10.1016\/j.det.2026.01.011_bib7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.clim.2003.12.007","article-title":"Development of an ELISA for the detection of autoantibodies to BP230","volume":"111","author":"Kromminga","year":"2004","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.det.2026.01.011_bib8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/archderm.135.2.143","article-title":"Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic tool","volume":"135","author":"Lenz","year":"1999","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.det.2026.01.011_bib9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2133.1998.02396.x","article-title":"Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C-terminal domains of the 180 kDa BP antigen (BP180): immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins","volume":"139","author":"Nakatani","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2026.01.011_bib10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jdrv.2024.07.003","article-title":"Mucous membrane pemphigoid and malignancy: Systematic review and meta-analysis of 1429 patients","volume":"1","author":"Kianfar","year":"2024","journal-title":"JAAD Reviews"},{"issue":"1","key":"10.1016\/j.det.2026.01.011_bib11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jaad.2020.05.161","article-title":"Subepithelial autoimmune bullous dermatoses disease activity assessment and therapy","volume":"85","author":"Montagnon","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2026.01.011_bib12","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jaad.2018.02.021","article-title":"Diagnosis and management of pemphigus: recommendations of an international panel of experts","volume":"82","author":"Murrell","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2026.01.011_bib13","article-title":"Real-world evaluation of the effectiveness and safety of dupilumab in bullous pemphigoid: an ambispective multicenter case series","author":"Planella-Fontanillas","year":"2024","journal-title":"Br J Dermatol"},{"issue":"16","key":"10.1016\/j.det.2026.01.011_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13164844","article-title":"Omalizumab and dupilumab for the treatment of bullous pemphigoid: a systematic review","volume":"13","author":"Granados-Betancort","year":"2024","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.det.2026.01.011_bib15","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/bjd\/ljad369","article-title":"Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients","volume":"190","author":"Chebani","year":"2024","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2026.01.011_bib129","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1684\/ejd.2017.3066","article-title":"The association between bullous pemphigoid and neurological disorders: a systematic review","volume":"27","author":"Milani-Nejad","year":"2017","journal-title":"Eur J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2026.01.011_bib130","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/jdv.15444","article-title":"Neurological disorders are associated with bullous pemphigoid","volume":"33","author":"Papakonstantinou","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.det.2026.01.011_bib131","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jamadermatol.2020.1587","article-title":"Association between medication use and bullous pemphigoid: a systematic review and meta-analysis","volume":"156","author":"Liu","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"15","key":"10.1016\/j.det.2026.01.011_bib132","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3457","article-title":"A systematic review of drug-induced pemphigoid","volume":"100","author":"Verheyden","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.det.2026.01.011_bib133","article-title":"The association between drugs and vaccines commonly prescribed to older people and bullous pemphigoid: a case-control study","author":"Swiderski","year":"2024","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2026.01.011_bib134","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/jamadermatol.2021.4773","article-title":"Evaluation of Site- and autoantigen-specific characteristics of mucous membrane pemphigoid","volume":"158","author":"van Beek","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.det.2026.01.011_bib135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaad.2021.11.061","article-title":"Insights into clinical and diagnostic findings as well as treatment responses in patients with mucous membrane pemphigoid: a retrospective cohort study","volume":"87","author":"Rashid","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2026.01.011_bib136","article-title":"Coexistence of Anti-p200 pemphigoid and psoriasis: a systematic review","volume":"13","author":"Xie","year":"2022","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.det.2026.01.011_bib137","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1111\/jdv.17465","article-title":"The burden of neurological comorbidities in six autoimmune bullous diseases: a population-based study","volume":"35","author":"Kridin","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.det.2026.01.011_bib52","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/ced.12114","article-title":"Epidermolysis bullosa acquisita and inflammatory bowel disease: a review of the literature","volume":"38","author":"Reddy","year":"2013","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.det.2026.01.011_bib64","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.semarthrit.2017.11.003","article-title":"Clinical, histological, immunological presentations and outcomes of bullous systemic lupus erythematosus: 10 new cases and a literature review of 118 cases","volume":"48","author":"de Risi-Pugliese","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.det.2026.01.011_bib70","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/ijd.17041","article-title":"Adult-onset linear IgA bullous dermatosis: a retrospective single-center cohort study of 81 patients and literature review","volume":"63","author":"Wang","year":"2024","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2026.01.011_bib138","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/07853890.2016.1222450","article-title":"Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease","volume":"49","author":"Collin","year":"2017","journal-title":"Ann Med"},{"issue":"9","key":"10.1016\/j.det.2026.01.011_bib76","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1365-4632.2007.03214.x","article-title":"3rd. Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: review of the Mayo clinic experience","volume":"46","author":"Alonso-Llamazares","year":"2007","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2026.01.011_bib80","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.jaad.2021.01.017","article-title":"Immunoglobulin M pemphigoid","volume":"85","author":"Boch","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2026.01.011_bib81","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1111\/ijd.16546","article-title":"Primary macroglobulinemia-induced immunobullous dermatosis: a systematic review","volume":"62","author":"Aromolo","year":"2023","journal-title":"Int J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2026.01.011_bib82","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15072","article-title":"Blistering lesions associated with waldenstr\u00f6m macroglobulinemia: new insights into pathogenesis","volume":"34","author":"Garcovich","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.det.2026.01.011_bib84","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jdcr.2024.01.004","article-title":"IgM-mediated epidermolysis bullosa acquisita","volume":"46","author":"Harrison","year":"2024","journal-title":"JAAD Case Rep"},{"issue":"3","key":"10.1016\/j.det.2026.01.011_bib139","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jaad.2019.07.029","article-title":"Associations of pemphigus or pemphigoid with autoimmune disorders in US adult inpatients","volume":"82","author":"Narla","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2026.01.011_bib140","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/ced.12634","article-title":"Pemphigus and associated comorbidities: a cross-sectional study","volume":"40","author":"Heelan","year":"2015","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.det.2026.01.011_bib141","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/bjd.13433","article-title":"Identification of a new disease cluster of pemphigus vulgaris with autoimmune thyroid disease, rheumatoid arthritis and type I diabetes","volume":"172","author":"Parameswaran","year":"2015","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2026.01.011_bib142","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jaad.2017.11.039","article-title":"Pemphigus and hematologic malignancies: a population-based study of 11,859 patients","volume":"78","author":"Kridin","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2026.01.011_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107299","article-title":"Drug-induced pemphigus: a systematic review of 170 patients","volume":"92","author":"Ghaedi","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"10.1016\/j.det.2026.01.011_bib99","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1111\/ijd.13025","article-title":"Clinicopathologic features of IgG\/IgA pemphigus in comparison with classic (IgG) and IgA pemphigus","volume":"55","author":"Toosi","year":"2016","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2026.01.011_bib100","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jaad.2019.11.059","article-title":"IgA pemphigus: a systematic review","volume":"82","author":"Kridin","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.det.2026.01.011_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103444","article-title":"Paraneoplastic autoimmune Laminin-332 syndrome (PALS): Anti-Laminin-332 mucous membrane pemphigoid as a prototype","volume":"22","author":"Ahmed","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.det.2026.01.011_bib89","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jaad.2024.10.013","article-title":"A systematic review of paraneoplastic pemphigus and paraneoplastic autoimmune multiorgan syndrome: clinical features and prognostic factors","volume":"92","author":"Zou","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2026.01.011_bib90","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/bjd.14162","article-title":"Clinical and immunological findings in 104 cases of paraneoplastic pemphigus","volume":"173","author":"Ohzono","year":"2015","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2026.01.011_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2023.08.020","article-title":"Paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome: part I. Clinical overview and pathophysiology","volume":"91","author":"Anderson","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2026.01.011_bib92","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaad.2023.08.084","article-title":"Paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome: part II. Diagnosis and management","volume":"91","author":"Huang","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.det.2026.01.011_bib21","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/cup.13343","article-title":"The spectrum of histopathologic findings in pemphigoid: avoiding diagnostic pitfalls","volume":"45","author":"Hodge","year":"2018","journal-title":"J Cutan Pathol"},{"issue":"4","key":"10.1016\/j.det.2026.01.011_bib24","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/cup.14358","article-title":"Histopathological features of pemphigoid gestationis and polymorphic eruption of pregnancy: a blinded retrospective comparative study of 31 cases","volume":"50","author":"Baban","year":"2023","journal-title":"J Cutan Pathol"},{"issue":"8","key":"10.1016\/j.det.2026.01.011_bib85","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/cup.14395","article-title":"Lymphocyte-predominant lesional inflammatory infiltrates of the skin are associated with mucosal-dominant phenotype in pemphigus","volume":"50","author":"Papara","year":"2023","journal-title":"J Cutan Pathol"},{"issue":"10","key":"10.1016\/j.det.2026.01.011_bib96","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/archdermatol.2012.1830","article-title":"Prognostic factors of paraneoplastic pemphigus","volume":"148","author":"Leger","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2026.01.011_bib69","article-title":"Histopathologic features in drug-induced, malignancy-associated, or idiopathic linear IgA bullous dermatosis: a retrospective comparative cohort study of 65 patients","author":"Wang","year":"2024","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.det.2026.01.011_bib144","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v104.11917","article-title":"Clinical features of paediatric inflammatory epidermolysis bullosa acquisita: a case series study","volume":"104","author":"Zhang","year":"2024","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.det.2026.01.011_bib16","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1046\/j.1365-2133.2003.05603.x","article-title":"Diagnostic value of an enzyme-linked immunosorbent assay using BP180 recombinant proteins in elderly patients with pruritic skin disorders","volume":"149","author":"Hofmann","year":"2003","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2026.01.011_bib17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/jdv.15883","article-title":"Characteristics of patients with bullous pemphigoid: comparison of classic bullous pemphigoid to non-bullous pemphigoid","volume":"34","author":"Ben","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.det.2026.01.011_bib18","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.autrev.2015.01.006","article-title":"Atypical presentations of bullous pemphigoid: clinical and immunopathological aspects","volume":"14","author":"Cozzani","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.det.2026.01.011_bib19","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1159\/000515954","article-title":"Non-bullous pemphigoid: a single-center retrospective study","volume":"237","author":"Moar","year":"2021","journal-title":"Dermatology"},{"issue":"7","key":"10.1016\/j.det.2026.01.011_bib20","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/1346-8138.13782","article-title":"Non-bullous lesions as the first manifestation of bullous pemphigoid: a retrospective analysis of 181 cases","volume":"44","author":"Zhang","year":"2017","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2026.01.011_bib22","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jaad.2017.11.029","article-title":"Serration pattern analysis for differentiating epidermolysis bullosa acquisita from other pemphigoid diseases","volume":"78","author":"Meijer","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2026.01.011_bib23","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jaad.2024.05.087","article-title":"Pemphigoid gestationis is associated with an increased risk for adverse pregnancy outcomes: a large-scale propensity-matched retrospective cohort study","volume":"91","author":"Preu\u00df","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2026.01.011_bib25","article-title":"Anti-laminin \u03b31 and \u03b24 antibodies in Anti-p200 pemphigoid","author":"Koga","year":"2024","journal-title":"J Invest Dermatol"},{"issue":"8","key":"10.1016\/j.det.2026.01.011_bib26","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1073\/pnas.0809230106","article-title":"Anti-laminin gamma-1 pemphigoid","volume":"106","author":"Dainichi","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.det.2026.01.011_bib27","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaad.2023.11.014","article-title":"Laminin \u03b24 is a constituent of the cutaneous basement membrane zone and additional autoantigen of anti-p200 pemphigoid","volume":"90","author":"Goletz","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2026.01.011_bib28","article-title":"Anti-laminin \u03b24 IgG drives tissue damage in Anti-p200 pemphigoid and shows interactions with laminin \u03b13 and \u03b31\/2 chains","author":"Pigors","year":"2024","journal-title":"J Invest Dermatol"},{"issue":"8","key":"10.1016\/j.det.2026.01.011_bib29","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jamadermatol.2016.1099","article-title":"Laboratory diagnosis and clinical profile of Anti-p200 pemphigoid","volume":"152","author":"Meijer","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2026.01.011_bib30","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3389\/fimmu.2019.02466","article-title":"Anti-p200 pemphigoid: a systematic review","volume":"10","author":"Kridin","year":"2019","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.det.2026.01.011_bib31","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s40257-022-00719-7","article-title":"Management of coexisting bullous pemphigoid and psoriasis: a review","volume":"23","author":"Hsieh","year":"2022","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"10.1016\/j.det.2026.01.011_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/DAD.0b013e31803326e6","article-title":"Histopathology of anti-p200 pemphigoid","volume":"29","author":"Rose","year":"2007","journal-title":"Am J Dermatopathol"},{"issue":"5","key":"10.1016\/j.det.2026.01.011_bib33","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4103\/ijdvl.IJDVL_678_16","article-title":"Epidermolysis bullosa acquisita and anti-p200 pemphigoid as major subepidermal autoimmune bullous diseases diagnosed by floor binding on indirect immunofluorescence microscopy using human salt-split skin","volume":"83","author":"Goyal","year":"2017","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"12","key":"10.1016\/j.det.2026.01.011_bib34","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/ijd.15699","article-title":"Inverted-U serration pattern: a novel clue for the diagnosis of anti-laminin-\u03b31 pemphigoid","volume":"60","author":"Senatore","year":"2021","journal-title":"Int J Dermatol"},{"issue":"9","key":"10.1016\/j.det.2026.01.011_bib35","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/1346-8138.16810","article-title":"Usefulness of immunofluorescence overlay antigen mapping in the identification of autoantigen in anti-p200 pemphigoid","volume":"50","author":"Kitayama","year":"2023","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2026.01.011_bib36","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jaad.2020.07.076","article-title":"Serologic characterization of anti-p200 pemphigoid: epitope spreading as a common phenomenon","volume":"84","author":"Holtsche","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2026.01.011_bib37","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3389\/fimmu.2019.01389","article-title":"Lichen planus pemphigoides: from lichenoid inflammation to autoantibody-mediated blistering","volume":"10","author":"H\u00fcbner","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.det.2026.01.011_bib38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1523-1747.1999.00618.x","article-title":"Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180","volume":"113","author":"Zillikens","year":"1999","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.det.2026.01.011_bib39","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1046\/j.1365-2133.1998.02262.x","article-title":"Lichen planus pemphigoides is a heterogeneous disease: a report of five cases studied by immunoelectron microscopy","volume":"138","author":"Bouloc","year":"1998","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2026.01.011_bib40","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/DAD.0000000000002139","article-title":"Lichen planus pemphigoides associated with PD-1 and PD-L1 inhibitors: a case series and review of the literature","volume":"44","author":"Boyle","year":"2022","journal-title":"Am J Dermatopathol"},{"issue":"8","key":"10.1016\/j.det.2026.01.011_bib41","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.jid.2023.02.012","article-title":"Disease endotypes predict the severity of mucous membrane pemphigoid","volume":"143","author":"Fairley","year":"2023","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.det.2026.01.011_bib42","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/jdv.13397","article-title":"A systematic review with pooled analysis of clinical presentation and immunodiagnostic testing in mucous membrane pemphigoid: association of anti-laminin-332 IgG with oropharyngeal involvement and the usefulness of ELISA","volume":"30","author":"Amber","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.det.2026.01.011_bib44","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/ced\/llae124","article-title":"Potential correlation between anti-laminin 332 autoantibodies and malignant tumours in anti-BP180-type mucous membrane pemphigoid","volume":"49","author":"Li","year":"2024","journal-title":"Clin Exp Dermatol"},{"issue":"10","key":"10.1016\/j.det.2026.01.011_bib45","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1080\/09273948.2024.2397715","article-title":"The role of serology in the diagnosis of ocular predominant mucous membrane pemphigoid and the search for an ocular-specific autoantigen","volume":"32","author":"Sodha","year":"2024","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"10.1016\/j.det.2026.01.011_bib46","article-title":"Ocular mucous membrane pemphigoid demonstrates a distinct autoantibody profile from those of other autoimmune blistering diseases: a preliminary study","volume":"13","author":"Liu","year":"2024","journal-title":"Antibodies (Basel)"},{"issue":"3","key":"10.1016\/j.det.2026.01.011_bib47","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jaad.2009.02.012","article-title":"Histopathology of anti-laminin 5 mucous membrane pemphigoid","volume":"61","author":"Rose","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2026.01.011_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12031139","article-title":"Epidermolysis bullosa Acquisita-Current and emerging treatments","volume":"12","author":"Te\u0161anovi\u0107 Perkovi\u0107","year":"2023","journal-title":"J Clin Med"},{"issue":"9","key":"10.1016\/j.det.2026.01.011_bib49","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.jid.2020.01.022","article-title":"Epidermal damage induces Th1 polarization and defines the site of inflammation in murine epidermolysis bullosa acquisita","volume":"140","author":"Niebuhr","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.det.2026.01.011_bib50","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/bjophthalmol-2019-313960","article-title":"Ocular involvement in epidermolysis bullosa acquisita with long-term follow-up","volume":"104","author":"Rousseau","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.det.2026.01.011_bib51","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1111\/1346-8138.17242","article-title":"Scarring alopecia and nail loss in a patient with epidermolysis bullosa acquisita","volume":"51","author":"Kusano","year":"2024","journal-title":"J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2026.01.011_bib53","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1046\/j.1523-1747.2002.01772.x","article-title":"The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with Crohn\u2019S disease have autoantibodies to type VII collagen","volume":"118","author":"Chen","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.det.2026.01.011_bib54","article-title":"Risk factors and sequelae of epidermolysis bullosa acquisita: a propensity-matched global study in 1,344 patients","volume":"13","author":"Kridin","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.det.2026.01.011_bib55","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2133.2004.06006.x","article-title":"U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases","volume":"151","author":"Vodegel","year":"2004","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2026.01.011_bib56","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3748","article-title":"Diagnostic value and practicability of serration pattern analysis by direct immunofluorescence microscopy in pemphigoid diseases","volume":"101","author":"Holtsche","year":"2021","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"10.1016\/j.det.2026.01.011_bib57","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jaad.2024.01.076","article-title":"U-serrated and n-serrated patterns in bullous pemphigoid, epidermolysis bullosa acquisita, and bullous lupus: a retrospective observational study","volume":"90","author":"Barker","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2026.01.011_bib58","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bjd.12308","article-title":"The n- vs. u-serration is a learnable criterion to differentiate pemphigoid from epidermolysis bullosa acquisita in direct immunofluorescence serration pattern analysis","volume":"169","author":"Terra","year":"2013","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.det.2026.01.011_bib59","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.ajpath.2021.05.024","article-title":"Use of convolutional neural networks for the detection of u-Serrated patterns in direct immunofluorescence images to facilitate the diagnosis of epidermolysis bullosa acquisita","volume":"191","author":"Shi","year":"2021","journal-title":"Am J Pathol"},{"key":"10.1016\/j.det.2026.01.011_bib60","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijmedinf.2018.11.007","article-title":"Detection of u-serrated patterns in direct immunofluorescence images of autoimmune bullous diseases by inhibition-augmented COSFIRE filters","volume":"122","author":"Shi","year":"2019","journal-title":"Int J Med Inform"},{"issue":"1","key":"10.1016\/j.det.2026.01.011_bib61","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/1523-1747.ep12285634","article-title":"Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita","volume":"108","author":"Chen","year":"1997","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.det.2026.01.011_bib62","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3774","article-title":"Diagnosis of epidermolysis bullosa acquisita: Multicentre comparison of different assays for serum anti-type VII collagen reactivity","volume":"101","author":"Holtsche","year":"2021","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.det.2026.01.011_bib63","doi-asserted-by":"crossref","first-page":"e384","DOI":"10.1111\/jdv.17926","article-title":"Subepidermal type VII collagen speckles as an additional clue for diagnosing epidermolysis bullosa acquisita by salt-split skin serum analysis","volume":"36","author":"Gribaleva","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"10.1016\/j.det.2026.01.011_bib65","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/DAD.0000000000002825","article-title":"Histopathologic overlap between bullous lupus erythematosus and linear IgA bullous dermatosis: a comparative study","volume":"46","author":"Murugesu","year":"2024","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"10.1016\/j.det.2026.01.011_bib66","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.21873\/anticanres.13432","article-title":"Bullous lupus under nivolumab treatment for lung cancer: a case report with systematic literature review","volume":"39","author":"Wouters","year":"2019","journal-title":"Anticancer Res"},{"issue":"6","key":"10.1016\/j.det.2026.01.011_bib67","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/archderm.144.6.774","article-title":"A morbilliform variant of vancomycin-induced linear IgA bullous dermatosis","volume":"144","author":"Billet","year":"2008","journal-title":"Arch Dermatol"},{"issue":"11","key":"10.1016\/j.det.2026.01.011_bib68","doi-asserted-by":"crossref","DOI":"10.5070\/D32311037271","article-title":"Flame figures in linear IgA bullous dermatosis: a novel histopathologic finding","volume":"23","author":"Fulton","year":"2017","journal-title":"Dermatol Online J"},{"issue":"3","key":"10.1016\/j.det.2026.01.011_bib71","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/pde.15567","article-title":"Linear IgA bullous dermatosis of childhood: retrospective single-center cohort","volume":"41","author":"Wang","year":"2024","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.det.2026.01.011_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.937528","article-title":"Linear immunoglobulin a bullous dermatosis in children","volume":"10","author":"Mori","year":"2022","journal-title":"Front Pediatr"},{"issue":"5","key":"10.1016\/j.det.2026.01.011_bib73","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/ced.15059","article-title":"Clinical features of chronic bullous dermatosis of childhood","volume":"47","author":"Wilson","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2026.01.011_bib74","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jdcr.2022.05.037","article-title":"Urticarial dermatitis herpetiformis: a rare presentation of an uncommon disorder","volume":"26","author":"Sally","year":"2022","journal-title":"JAAD Case Rep"},{"issue":"9","key":"10.1016\/j.det.2026.01.011_bib75","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jdcr.2020.07.032","article-title":"Acral petechial eruptions without gastrointestinal symptoms: three cases of dermatitis herpetiformis","volume":"6","author":"Simpson","year":"2020","journal-title":"JAAD Case Rep"},{"issue":"4","key":"10.1016\/j.det.2026.01.011_bib77","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1600-0560.2009.01472.x","article-title":"Fibrillar IgA deposition in dermatitis herpetiformis--an underreported pattern with potential clinical significance","volume":"37","author":"Ko","year":"2010","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.det.2026.01.011_bib78","article-title":"A comparative study of direct immunofluorescence patterns in linear IgA bullous dermatosis versus dermatitis herpetiformis","author":"Sagut","year":"2024","journal-title":"Am J Dermatopathol"},{"issue":"9","key":"10.1016\/j.det.2026.01.011_bib79","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3914","article-title":"Persistent skin symptoms after diagnosis and on a long-term gluten-free diet in dermatitis herpetiformis","volume":"101","author":"Pasternack","year":"2021","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.det.2026.01.011_bib83","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/DAD.0b013e3182604854","article-title":"Bullous tinea pedis with direct immunofluorescence positivity: when is a positive result not autoimmune bullous disease?","volume":"35","author":"Miller","year":"2013","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"10.1016\/j.det.2026.01.011_bib86","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/cup.12037","article-title":"Diagnostic utility of direct immunofluorescence findings around hair follicles and sweat glands in immunobullous disease","volume":"40","author":"Lehman","year":"2013","journal-title":"J Cutan Pathol"},{"issue":"3","key":"10.1016\/j.det.2026.01.011_bib87","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/cup.12272","article-title":"Punctate pemphigus: an underreported direct immunofluorescence pattern","volume":"41","author":"Ko","year":"2014","journal-title":"J Cutan Pathol"},{"issue":"4","key":"10.1016\/j.det.2026.01.011_bib88","doi-asserted-by":"crossref","first-page":"620","DOI":"10.4103\/idoj.idoj_586_23","article-title":"Diagnostic utility of immunofluorescence on formalin-fixed paraffin-embedded skin biopsy","volume":"15","author":"Das","year":"2024","journal-title":"Indian Dermatol Online J"},{"issue":"2","key":"10.1016\/j.det.2026.01.011_bib93","first-page":"193","article-title":"Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus","volume":"137","author":"Nguyen","year":"2001","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.det.2026.01.011_bib94","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jaad.2006.06.007","article-title":"Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies","volume":"56","author":"Cummins","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2026.01.011_bib95","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/bjd.17577","article-title":"Decreased recognition of paraneoplastic pemphigus in patients previously treated with anti-CD 20 monoclonal antibodies","volume":"180","author":"Kwatra","year":"2019","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.det.2026.01.011_bib97","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/cup.14004","article-title":"Paraneoplastic pemphigus: revised diagnostic criteria based on literature analysis","volume":"48","author":"Svoboda","year":"2021","journal-title":"J Cutan Pathol"},{"issue":"1","key":"10.1016\/j.det.2026.01.011_bib98","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jaad.2020.07.126","article-title":"A retrospective study on the clinicopathologic features of IgG\/IgA pemphigus","volume":"85","author":"Criscito","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2026.01.011_bib101","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jdcr.2024.02.025","article-title":"IgA pemphigus as an immune checkpoint inhibitor-associated skin manifestation","volume":"47","author":"Bruijn","year":"2024","journal-title":"JAAD Case Rep"},{"issue":"7","key":"10.1016\/j.det.2026.01.011_bib102","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamadermatol.2025.0339","article-title":"Assessment of cutaneous and mucosal direct immunofluorescence testing practices in the US","volume":"161","author":"Lehman","year":"2025","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.det.2026.01.011_bib103","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jaad.2024.08.055","article-title":"Diagnostic value of direct immunofluorescence testing in the evaluation of alopecia: a single-institution retrospective cohort study of 346 specimens","volume":"91","author":"Colbert","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2026.01.011_bib104","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jaad.2024.07.1486","article-title":"Direct immunofluorescence testing for skin and mucosal ulcerations: a retrospective cohort study of 352 specimens","volume":"91","author":"Lehman","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2026.01.011_bib105","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jaad.2017.05.016","article-title":"Multiple and repeated sampling increases the sensitivity of direct immunofluorescence testing for the diagnosis of mucous membrane pemphigoid","volume":"77","author":"Shimanovich","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2026.01.011_bib106","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jaad.2025.03.020","article-title":"Diagnostic yield of testing an additional direct immunofluorescence specimen derived at a single timepoint: a retrospective cohort study of 1438 direct immunofluorescence specimen pairs","volume":"93","author":"Saeidi","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.det.2026.01.011_bib107","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/cup.12393","article-title":"Pre-bisection of a single skin biopsy does not produce technically inadequate specimens for direct immunofluorescence: a review of 3450 specimens","volume":"41","author":"Loh","year":"2014","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.det.2026.01.011_bib108","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-5945-4-10","article-title":"Enhanced diagnostic immunofluorescence using biopsies transported in saline","volume":"4","author":"Vodegel","year":"2004","journal-title":"BMC Dermatol"},{"issue":"10","key":"10.1016\/j.det.2026.01.011_bib109","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/cup.13494","article-title":"A comparative study of Michel\u2019s medium versus honey as a transport medium for skin specimens prior to direct immunofluorescence microscopy and antigen mapping","volume":"46","author":"Kumudhini","year":"2019","journal-title":"J Cutan Pathol"},{"issue":"3","key":"10.1016\/j.det.2026.01.011_bib110","article-title":"Diagnostic utility of direct immunofluorescence on paraffin-embedded skin biopsy samples for the diagnosis of autoimmune vesiculobullous lesions","volume":"16","author":"Bk","year":"2024","journal-title":"Cureus"},{"issue":"11","key":"10.1016\/j.det.2026.01.011_bib111","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1001\/jamadermatol.2021.3892","article-title":"Assessment of clinical and laboratory use of the cutaneous direct immunofluorescence assay","volume":"157","author":"Reimann","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.det.2026.01.011_bib112","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/cup.14176","article-title":"Impact of adding an IgG4 conjugate to routine direct immunofluorescence testing for subepithelial and intraepithelial autoimmune blistering disorders","volume":"49","author":"Lehman","year":"2022","journal-title":"J Cutan Pathol"},{"issue":"9","key":"10.1016\/j.det.2026.01.011_bib145","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/cup.14835","article-title":"Clinical, serologic, and histopathologic features of patients with pemphigus with either positive or negative IgG4 intercellular deposition by direct immunofluorescence (DIF): A retrospective case-control study of 55 DIF biopsy specimens","volume":"52","author":"Garbanzos","year":"2025","journal-title":"J Cutan Pathol"},{"issue":"2","key":"10.1016\/j.det.2026.01.011_bib113","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/DAD.0000000000002885","article-title":"Immunohistochemistry for immunoglobulin G4 on paraffin sections as a diagnostic test for pemphigus","volume":"47","author":"Abadjieva","year":"2025","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.det.2026.01.011_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2024.152367","article-title":"Diagnosis of autoimmune bullous dermatoses: comparative analysis of immunohistochemical staining using C4d, C3d, IgG, and IgG4 in lesional tissues and perilesional frozen skin samples","volume":"73","author":"Karaba\u011f","year":"2024","journal-title":"Ann Diagn Pathol"},{"issue":"5","key":"10.1016\/j.det.2026.01.011_bib115","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4103\/ijd.ijd_386_22","article-title":"Immunohistochemical evaluation of C4d and C3d markers in bullous pemphigoid as a substitute for direct immunofluorescence technique","volume":"68","author":"Oryani","year":"2023","journal-title":"Indian J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2026.01.011_bib116","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jaad.2008.06.022","article-title":"The use of C3d and C4d immunohistochemistry on formalin-fixed tissue as a diagnostic adjunct in the assessment of inflammatory skin disease","volume":"59","author":"Magro","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.det.2026.01.011_bib117","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/DAD.0000000000001817","article-title":"Immunoglobulin and complement immunohistochemistry on paraffin sections in autoimmune bullous diseases: a systematic review and meta-analysis","volume":"43","author":"Kasperkiewicz","year":"2021","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.det.2026.01.011_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.abd.2024.04.014","article-title":"Collagen IV immunohistochemistry and autoimmune bullous diseases: defining the location of the subepidermal bullae","author":"Nieto-Benito","year":"2025","journal-title":"An Bras Dermatol"},{"issue":"2","key":"10.1016\/j.det.2026.01.011_bib119","first-page":"133","article-title":"The value of type IV collagen immunohistochemical staining in the differential diagnosis of autoimmune subepidermal bullous diseases","volume":"26","author":"Yeol Lee","year":"2018","journal-title":"Acta Dermatovenerol Croat"},{"issue":"2","key":"10.1016\/j.det.2026.01.011_bib120","first-page":"141","article-title":"Autoimmunity in chronic bullous skin diseases. Immunofluorescent demonstration of three types of antibodies to skin in sera of patients with pemphigus, bullous pemphigoid and in other human sera","volume":"2","author":"Beutner","year":"1967","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.det.2026.01.011_bib121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00403-007-0734-0","article-title":"The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases","volume":"299","author":"Sitaru","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.det.2026.01.011_bib122","article-title":"Indirect immunofluorescence testing for immunoglobulin (Ig)G4 and IgG increases test sensitivity over that of indirect immunofluorescence testing for IgG alone for pemphigoid and pemphigus diseases: a retrospective study of 278 cases","author":"Lehman","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.det.2026.01.011_bib123","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/jamadermatol.2024.3425","article-title":"Bullous pemphigoid severity and levels of antibodies to BP180 and BP230: a systematic review and meta-analysis","volume":"160","author":"Chou","year":"2024","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.det.2026.01.011_bib124","first-page":"312","article-title":"Serologic biomarkers in pemphigus monitoring: C-reactive protein, macrophage migration inhibitory factor, and prolactin levels versus autoantibody assays","volume":"22","author":"Mortazavi","year":"2023","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"10.1016\/j.det.2026.01.011_bib125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jdrv.2024.07.008","article-title":"Longitudinal monitoring of enzyme-linked immunosorbent assay for NC16A-BP180 or BP230 antibodies as a biomarker of disease activity in pemphigoid: a systematic review","volume":"1","author":"Privalle","year":"2024","journal-title":"JAAD Reviews"},{"issue":"10","key":"10.1016\/j.det.2026.01.011_bib126","first-page":"1103","article-title":"Evaluation of a newly available ELISA for envoplakin autoantibodies for the diagnosis of paraneoplastic pemphigus","volume":"14","author":"Powell","year":"2015","journal-title":"J Drugs Dermatol"},{"issue":"11","key":"10.1016\/j.det.2026.01.011_bib127","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/1346-8138.12278","article-title":"Anti-type VII collagen autoantibodies, detected by enzyme-linked immunosorbent assay, fluctuate in parallel with clinical severity in patients with epidermolysis bullosa acquisita","volume":"40","author":"Ito","year":"2013","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2026.01.011_bib128","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/bjd.17202","article-title":"A sensitive and specific assay for the serological diagnosis of antilaminin 332 mucous membrane pemphigoid","volume":"180","author":"Goletz","year":"2019","journal-title":"Br J Dermatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863526000112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863526000112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T22:36:17Z","timestamp":1775514977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863526000112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":145,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0733863526000112"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2026.01.011","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis of Autoimmune Blistering Diseases","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2026.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}